PAVmed Inc (PAVM)
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Astria Therapeutics Inc. (ATXS)
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Evaxion Biotech A/S (EVAX)
Evaxion announce 2026 financial calendar
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Reviva Pharmaceuticals Holdings Inc. (RVPHW)
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025
Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Cassava Sciences Inc. (SAVAW)
Cassava Reports Q3 2025 Financials Results and Provides Business Update
Bespoke Extracts, Inc. (BSPK)
Bespoke Extracts, Inc. Reports Third Quarter 2025 Results – The Joint Company Scales Colorado Production and Margin Leadership
Collegium Pharmaceutical Inc (COLL)
Collegium to Participate in Upcoming Investor Conferences
Leap Therapeutics Inc (LPTX)
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results